ESR1 and breast cancer: Another group demonstrated that miR-342 expression was positively correlated with ERα mRNA expression in human breast cancer cell lines and proposed that it could predict TAM sensitivity in ERα-positive breast cancer and become a potential target for restoring ERα expression and response to antiestrogen therapy [30].